Elevance Raises $100 Million in Funding Round

Biomaterials start-up Elevance has raised $100 million in a Series C funding round, the company announced today. The funding round is the company's third. Naxos Capital partners led the round. Other investors included Total Energy Ventures and TPG Biotech. TPG has been an investor in Elevance since 2007. The proceeds from the funding will go towards the construction and expansion of biorefineries. Earlier this year, Elevance entered into a joint venture with Wilmar International (Singapore), a maker of palm oils, to build the world's largest biorefinery in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers